Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04610671
Title Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

bladder urothelial carcinoma

Therapies

CG0070 + Nivolumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.